Albumin, as a multifunctional drug target carrier and a functional carrier that improves the pharmacokinetic properties of peptide and protein drugs in vivo, plays an increasingly important role in the clinical application of drugs. CD Formulation, a top formulation development service provider, offers our clients albumin nanoparticle formulation development services using our advanced technology. Our professional nanoformulation team can design and create our high-quality albumin nanoparticles tailored to your various needs, supporting research and potential commercialization in the field of nanomedicine.
Albumin, also known as serum protein, has a wide range of sources. Albumin is extracted from different sources such as Ovalbumin (OVA), Bovine Serum Albumin (BSA), Human Serum Albumin (HSA) and Rat Serum Albumin (RSA). Albumin can be bound to a variety of molecules and substances, including therapeutic drugs, antibodies and peptides.
Fig.1 Albumin can bind to a broad range of molecules. (Elmira Karami, et al. 2020)
Albumin has the characteristics of good biocompatibility, non-toxicity, and non-immunogenicity, and its application in new drug delivery carriers continues to increase. Especially for tumor treatment, albumin nanoparticles, as drug delivery carries, have the following advantages:
Fig.2 Advantages of albumin nanoparticles as drug delivery carriers. (CD Formulation)
Albumin nanoparticles encapsulate drugs in albumin nanoparticle delivery systems. Drugs can be covalently bound to the spatial structure of albumin or attached to the surface of the delivery system through physical adsorption. Currently, there are also more advanced technologies to incorporate drugs into the matrix of nanoparticles. We are committed to albumin nanoparticle research and development. we can provide you with comprehensive and professional solutions and helps you quickly develop the formulation of high-quality albumin nanoparticles for nanomedicine.
We can choose appropriate physical and chemical methods to prepare albumin nanoparticles based on the characteristics of the active drugs. In the preparation of albumin nanoparticles, chemical methods include desolvation, emulsification and self-assembly. At the same time, we can also use thermal gelation, nanoparticle albumin binding (NAB) technology and nanospray drying to produce albumin nanoparticles using physical techniques. In addition, we can also use some special methods (e.g., covalent bonding, surface coating, and electrostatic adsorption) to load albumin nanoparticles onto targeted drugs.
In addition to the special methods mentioned earlier, we offer additional techniques for creating albumin nanoparticles as needed. We can also customize the surface of these nanoparticles with modifications such as altered cell-penetrating peptides, adjustments using natural substances, and other functional changes.
The durability of albumin nanoparticles over an extended period of storage can be assessed by observing alterations in their form, size, zeta potential, encapsulation efficiency, drug content, in vitro drug release, and overall appearance over time. We offer an array of analyses and characterizations for albumin nanoparticles including:
Technology: Chemometric technique for preparation of human serum albumin nanoparticles (HSA)
Journal: Journal of Nanostructure in Chemistry
IF: 10.7
Published: 2017
Results:
The authors applied chemometric methods for size optimization of human serum albumin (HSA) nanoparticles. The influence of three experimental parameters, such as pressure (P) or power, organic solvent volume (V) and time (T), under sonication and high-pressure homogenization, was studied using multivariate analysis. The method was optimized in response to the size of the nanoparticles.
CD Formulation is a leader in the development of albumin nanoparticle formulations. And our team can quickly respond to the different needs of customers in albumin nanoparticle development services. If you need our services, please contact us via phone or email, and our team will respond to you within three business days.
References